cd13

cd13cd13
  1. Results : 90 % cells were CD13 , CD44 positive mesenchymal stem cells .

    结果:所分离细胞约90%表达间充质干细胞表面抗原CD13、CD44。

  2. The high expression of CD13 antigen ;

    有CD13高表达抗原;

  3. Expression of Aminopeptidase N / CD13 and Its Clinical Significance in Non-small Cell Lung Cancer

    非小细胞肺癌氨肽酶N/CD13的表达及临床意义

  4. The adipose stem cells expressed CD13 and CD44 through immunofluorescence .

    免疫荧光法鉴定脂肪基质干细胞表达CD13和CD44。

  5. Changes of CD13 / APN expression in peripheral blood of patients with advanced psoriasis before and after treatment

    银屑病进展期患者治疗前后外周血CD13/APN的表达变化

  6. Expression and Clinical Significance of CD10 , CD13 and CTAg in Primary Pulmonary Carcinoma

    CD10、CD13和CTAg在原发性肺癌中表达的临床研究

  7. In the terminal stage , the CD13 + cells accounted for 10.15 % of bone marrow cells in model animal .

    发病晚期,模型动物骨髓细胞中CD13+细胞占10.15%;

  8. Results : The expression rates of medullary cell CD34 , CD13 / CD33 in the treatment group were decreased .

    结果:治疗组骨髓细胞CD34表达率及CD13/CD33表达率有所下降。

  9. The expression rates of medullary cell CD34 , CD13 / CD33 were observed before and after the treatment .

    观察治疗前后患者骨髓细胞CD34、CD13/CD33表达率。

  10. Previous studies indicated that HCC cells expressed high levels of APN / CD13 , which might be related with the metastatic behavior of HCC .

    既往的研究表明,HCC细胞株APN/CD13表达水平较高,可能与其易发生转移的行为有关。

  11. The blast cells expressed stem cell associated antigens CD34 , HLA-DR and myeloid antigens CD33 , CD13 , MPO .

    原始细胞表达干细胞相关抗原CD34、HLA-DR和髓系抗原CD33、CD13、MPO。

  12. Synthesis and preliminary activity assay in vitro of cinnamoyl asparagines derivatives as aminopeptidase N ( APN / CD13 ) inhibitors

    肉桂酰天冬氨酸类氨肽酶N抑制剂的合成和初步活性研究

  13. Cell apoptosis , cell cycle shift and expression of myeloid-specific differentiation antigen ( CD11b , CD13 ) were analyzed by flow cytometry ( FCM ) .

    流式细胞术分析细胞凋亡、细胞周期变化和髓系分化抗原CD11b、CD13的表达情况;

  14. Conclusion : The leukemia animal model could be successfully established by transplanting K562 cells into SCID mice . Positive rate of CD13 might be used as the index of tumor cells infiltration .

    结论:SCID小鼠接种K562白血病细胞能成功建立白血病动物模型,CD13阳性率能快速、客观地判断模型中肿瘤细胞浸润程度。

  15. Results : Lymphoblastic antigens in all acute lymphoblastic leukemia cases were expressed , in which CD13 and CD33 were 46.7 % and 11.1 % , respectively ;

    结果:急性淋系白血病细胞均表达淋系抗原,46.7%和11.1%的成人ALL细胞表达CD13和CD33;

  16. The alterations of the expressions of CD33 , CD13 , CD71 , CD19 and CD3 as well as the cell cycle were determined by flow cytometry .

    用流式细胞术检测上述培养细胞上各种表型分子CD33、CD13、CD71、CD19、CD3表达的变化和细胞周期的改变。

  17. Myeloid-associated antigen expressed in 24.5 % of the ALL especially CD13 ( 17.80 % ) and CD33 ( 11.10 % ) .

    24.5%的ALL表达髓系相关抗原,主要是CD13(17.80%)及CD33(11.10%)。

  18. Results Among the 71 cases of AML , CD33 , CD13 and HLA-DR were the most commonly expressed antigen ( 97.2 % , 94.4 % and 69 % respectively ) .

    结果在儿童急性髓系白血病患者中,CD33和CD13的表达最常见,分别达97.2%和94.4%,其次为HLADR(69%)。

  19. Expression of myeloid cell differentiation antigens CD 11b and CD13 induced by PB was enhanced when Kasumi 1 cells were pretreated with low dose of 5 Aza CdR .

    低剂量5AzaCdR增强PB诱导Kasumi1细胞髓系分化抗原CD11b和CD13的表达。

  20. In Vitro Study on the Enhancement of Aminopeptidase N / CD13 Inhibitor Ubenimex on the Inducing-differentiation Activity of All-trans-retinoic Acid in Acute Promyelocytic Leukemia Cells and the Mechanism of This Effect

    氨肽酶N/CD13抑制剂乌苯美司增强全反式维甲酸诱导急性早幼粒白血病细胞分化作用及其机制的研究

  21. Conclusion : Jiaweiqinghao biejia soup has restraining effect on the expression rate of medullary cell CD34 , CD13 / CD33 of acute myelocytic leukemia in catabatic period .

    结论:加味青蒿鳖甲汤对急性髓系白血病缓解期患者骨髓细胞CD34、CD13/CD33表达有抑制作用。

  22. The results showed that MPO , CD13 and CD33 were almost expressed in all patients with APL and CML-CP whereas HLA-DR and CD34 , the hematopoietic progenitor cell markers , were rarely expressed .

    结果表明APL与CML慢性期都高表达MPO、CD13和CD33,而几乎不表达CD34、HLA-DR及T,B淋巴系列标志。

  23. Results : The medians of CD13 and CD33 of My + B-ALL and My + T-ALL were all higher than My-B-ALL and My-T-ALL ( P < 0.01 , P < 0.05 ) .

    结果:My+B-ALL和My+T-ALL患者的CD13及CD33的中位数均高于My-B-ALL和My-T-ALL患者,其表达率均显著高于My-B-ALL和My-T-ALL患者(P<0.01,P<0.05)。

  24. For myeloid antigens , CD33 was the hightest to 25.7 % , and CD13 was up to 24.2 % , but CD15 and CD11b were uncommon , the positive rates were 5.7 % and 1.4 % respectively .

    B系ALL表达髓系抗原以CD33最高达25.7%,CD13次之达24.2%,CD15和CD11b较少见,分别占5.7%和1.4%。

  25. Conclusion : The detection on expression of CD13 and CD33 by FCM in APL can predict relapse . The results of FCM analysis could improve the sensitivity of MRD detection and estimate the prognosis of APL patients . Co-expression of CD13 and CD33 might indicate poor outcome of APL .

    结论研究结果推断,应用FCM检测APL病人CD13和CD33表达可预测复发,FCM分析结果可提高检测MRD的敏感性并可估计APL病人的预后,CD13和CD33双表达可能预后不良。